GAVRETO FDA approval date

The FDA approved GAVRETO on 4 Sep 2020.

FDA approval date
4 Sep 2020

Drug identity has not yet been verified against registry records

Also recorded as PRALSETINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-09-04DayGAVRETOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213721", "applicant_as_listed_by_fda": "RIGEL PHARMS", "brand_names": ["GAVRETO"], "active_ingredients": ["PRALSETINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200904", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026